Proteoblood

French-Spanish network for the development of individualized therapies in hematological cancers. Cutting-edge technologies to study tumor microenvironment.

[Proteoblood @proteoblood]

🇬🇧ENG (1/6)- What is PROTEOblood? It is a Franco-Spanish network for the development of personalized therapies in 2 very common 🩸blood cancers but with little therapeutic alternative: Diffuse Large B-Cell Lymphoma (DLBCL) and Acute Myeloid Leukemia (AML)

[Gaël Roué @gaelroueBCN]

Eager to learn about the latest achievements of the 2014-2020 #poctefa program, in which we participate through the @proteoblood project @roue_s @CarrerasIJC @europeanunion #Bilbao

[Manel Esteller @ManelEsteller]

Ahir #PhDDayCanRuti @canrutiphd amb els investigadors predoctorals de tot el campus #Badalona @CarrerasIJC @GTRecerca @Irsicaixa @hgermanstrias, força pedrera!

[Sarry Lab @jeansarry]

Chers amis du consortium CEBPAML j'ai porté au mieux cette nouvelle histoire doublée d'une collaboration incroyable ce matin à la session Molecular Hematopoiesis de l' #EHA. Enormes mercis à Marie Sabatier, Rudy Birsen et Jérome Tamburini de l'#UNIGeneva de me permettre tout çà!

[Proteoblood @proteoblood]

Notre coordinateur @gaelroueBCN de @institutjosepcarreras résume en quoi a consisté le travail de notre consortium
L'objectif est d'étudier les altérations protéiques dans deux types de cancers du 🩸 la #leucémie et le #lymphome, et de développer des traitements personnalisés

[Proteoblood @proteoblood]

Nuestro coordinador el @gaelroueBCN @institutjosepcarrera resume en que ha consistido el trabajo de nuestro consorcio. El objetivo es estudiar las alteraciones proteicas en dos tipos prevalentes de cánceres de la🩸, #leucemia y #linfoma y desarrollar tratamientos personalizados

[Proteoblood @proteoblood]

Incredible teamwork that is showing interesting and very promising results in the search of novel therapeutic targets and the development of innovative preclinical models of #lymphoma #DLBCL and #leukemia #AML

[Proteoblood @proteoblood]

These last days we have held at @institutjosepcarreras the last annual PROTEOBLOOD meeting. Two days full of scientific discussions and laboratory practices with our extraordinary partners and friends from the consortium.

[Proteoblood @proteoblood]

Last but not least @JiBorrell and @GemaGorjon
from @IQS have isolated a first set of selective pharmacological hits against #LUBAC ubiquitin ligase complex, with promising activity in DLBCL and AML preclinical models which has been tested in @CarrerasIJC

[Gaël Roué @gaelroueBCN]

Enormously satisfied to have been able to hold this 2-days meeting in person at @CarrerasIJC , sharing scientific discussions and laboratory practices with our extraordinary partners and friends from the @proteoblood consortium.

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

➕We're glad to receive today in our Institute researchers from the centers involved in @proteoblood to hold the Closure Meeting of the project. Cooperation is key in research and this project is an example of it!👏

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

🤝The Spanish-French project @proteoblood coordinated by our Group Leader @GaelRoueBCN, from the Lymphoma Translational lab (@roue_s).

Its aim is to study hemostatic proteins in two prevalent types of #leukemia and #lymphoma and develop personalized treatments to cure them.

[Manel Esteller @ManelEsteller]

Ens fa il·lusió haver rebut al @CarrerasIJC alumnes de 4art ESO de l’escola Mare de Deu de la Mercè @mercedaries de Sant Feliu de Llobregat, els nostres investigadors @gaelroueBCN i @belverlab els han fet participar de la vida del centre dins el programa #Insticiència

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

El @CarrerasIJC ha sido seleccionado por @theNCI con el apoyo del Ministerio de @CienciaGob para el proyecto #ProteomaDelCáncer, una iniciativa internacional para el estudio de los tumores malignos.

Lee aquí la notícia➡️ https://t.co/e6xx4246TJ

[Gaël Roué @gaelroueBCN]

Great talk yesterday by our dear PhD fellow @marmencu8 explaining the main outcomes and perspectives of the #DLBCL #3dmodeling work package of the @proteoblood project coordinated by @CarrerasIJC @roue_s 👏

[Proteoblood @proteoblood]

We've talked, among other subjects, about the existing and future innovative preclinical models of cancer developed by @roue_s and the ongoing studies at @IQSbarcelona and potential applications for the design of anti-cancer therapies. Great science 🧬🔬⚗️!!!

[Proteoblood @proteoblood]

💡Finally the health situation has enabled us to held a face2face meeting at @CarrerasIJC between @roue_s and our partners from the Pharmaceutical Chemistry Group from @IQSbarcelona to share our joint effort searching for new treatments against 🩸#leukemia 🩸 and 🩸#lymphoma 🩸